Source: Willamette Week

Oregon Department of Corrections infectious disease specialist Dr. Daniel Dewsnup recently requested the antimalarial drug to treat inmates afflicted with the coronavirus, department spokeswoman Jennifer Black said.

The department purchased the drug “both for usual use as an anti-inflammatory drug in patients with rheumatologic disorders, and also a limited quantity for COVID-19 use,” Black said in an email to WW.

Black later clarified that the department did not order additional hydroxychloroquine solely for COVID-19 treatment, because its pharmacies already have a sufficient supply on hand.

She says ODOC would treat patients afflicted with COVID-19 with hydroxychloroquine, but declined to tell WW how many inmates, if any, it had treated with the drug.

Last month, the Oregon Pharmacy Board approved the drug “for a seriously ill patient in an institutional setting, such as Correctional Facilities and Long-Term Care Facilities, who would otherwise be hospitalized,” the Associated Press reported.

See the original article:

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »